The Chillery — Europe’s first high-end CBD retail platform, based out of London are aspiring to be the Net-A-Porter of all things CBD — and in doing so change the perception of CBD for women. The Chillery are bringing CBD to the luxury cbd skincare market.
The Net-A-Porter of CBD
The site is the brainchild of LA-native Marisa Schwab and Berlin-born Floriane von der Forst, who first met at university in Barcelona before sharing a flat in Notting Hill several years later.
Having built successful careers in the health (Schwab) and beauty (Von der Forst) industries, the duo joined forces to launch their latest venture just a week ago. It was the London grind that led to their light-bulb moment.
“We were in a stressful city, in stressful jobs and we both decided we needed a break,” says von der Forst.
That break was a week-long wellness retreat in Devon — an experience she describes as “life-changing for us” and which led to an all-natural overhaul on their return. A business plan that had CBD at its core was developed.
CBD for beauty, sleep, stress, pain and intimacy
The Chillery, has an aesthetically pleasing homepage featuring lush ferns and products divided into five categories spanning beauty, sleep, stress, pain and sexual intimacy with CBD lube. To help the uninitiated understand how to use CBD, there’s also straightforward guidance which shines a spotlight on the grey areas of the emerging industry. This includes CBD 101 cheat sheets, dosing basics and a guide that highlights the difference between THC — the mind-altering, high-inducing psychoactive most commonly associated with cannabis — and non-psychoactive CBD.
“Our customer is a modern woman looking for ways to improve her wellness regime — whether that’s a natural sleeping aid, or replacing five different beauty creams with one”, Von der Forst told the Evening Standard.
RELATED: How can CBD potentially impact on diabetes & obesity?
Consumer demand is high and growing. Women seem to run the CBD space but the compound is less backed by research. A Forbes article last Friday claimed women are underrepresented in clinical research on cannabis. It is hoped that the world is opening up access to CBD and gender bias in new clinical research and trials is avoided. Women have much to gain from being included.
